FORM N-PX PROXY VOTING RECORD
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | COLUMN 9 | COLUMN 10 | COLUMN 11 | COLUMN 12 | COLUMN 13 | COLUMN 14 | COLUMN 15 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NAME OF ISSUER |
CUSIP | ISIN | FIGI | MEETING DATE | VOTE DESCRIPTION | VOTE CATEGORY | DESCRIPTION OF OTHER CATEGORY | VOTE SOURCE | SHARES VOTED | SHARES ON LOAN | DETAILS OF VOTE | MANAGER NUMBER | SERIES ID | OTHER INFO | ||
| HOW VOTED | SHARES VOTED | FOR OR AGAINST MANAGEMENT | ||||||||||||||
| APPLIED DIGITAL CORPORATION | 038169207 | US0381692070 | - | 11/20/2024 | Approve, on an advisory basis, the executive compensation of the Company's named executive officers as described in the proxy statement | SECTION 14A SAY-ON-PAY VOTES |
- | - | 7716050 | 0 | FOR |
7716050 |
FOR |
- | - | |
| RECURSION PHARMACEUTICALS INC | 75629V104 | US75629V1044 | - | 06/18/2025 | Advisory vote to approve executive compensation as described in the 2025 Proxy Statement | SECTION 14A SAY-ON-PAY VOTES |
- | - | 0 | 0 | - | - | ||||
[Repeat as Necessary]